Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Neal

Showing results (231-240 of 260) with videos related to

Pageof 26
Sort By:
The Lancet. Diabetes & Endocrinology|September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trialsClaire Vale, Peter J Godolphin, David Fisher, et al.
The Journal of Clinical Investigation|November 10, 2015
Platelet-derived HMGB1 is a critical mediator of thrombosisSebastian Vogel, Rebecca Bodenstein, Qiwei Chen, et al.
Nature Communications|November 10, 2022
Lipidomic signatures align with inflammatory patterns and outcomes in critical illnessJunru Wu, Anthony Cyr, Danielle S Gruen, et al.
Trauma Surgery & Acute Care Open|January 23, 2025
High-grade liver injury: outcomes with a trauma surgery-liver surgery collaborative approachRafael G Ramos-Jimenez, Andrew-Paul Deeb, Evelyn I Truong, et al.
The Journal of Trauma and Acute Care Surgery|February 17, 2025
Predictive value of platelet function assays in traumatic brain injury patients on antiplatelet therapyNijmeh Alsaadi, Reem Younes, Jack R Killinger, et al.
Research and Practice in Thrombosis and Haemostasis|July 4, 2025
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trialSylvain A Lother, Wen Teng, Olawale Ayilara, et al.
Nature Nanotechnology|July 19, 2022
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motifMichelle A Cruz, Dillon Bohinc, Elizabeth A Andraska, et al.
Annals of Surgery|October 16, 2020
Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma TrialsJohn B Holcomb, Ernest E Moore, Jason L Sperry, et al.
Circulation|June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled TrialScott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.
The Journal of Trauma and Acute Care Surgery|January 23, 2026
Platelet function assays fail to detect differences between transfusion of cold or room temperature platelets in traumatic brain injury patientsJack R Killinger, Nijmeh Alsaadi, James F Luther, et al.
Pageof 26

Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
The Lancet. Diabetes & Endocrinology|September 9, 2024
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trialsClaire Vale, Peter J Godolphin, David Fisher, et al.
The Journal of Clinical Investigation|November 10, 2015
Platelet-derived HMGB1 is a critical mediator of thrombosisSebastian Vogel, Rebecca Bodenstein, Qiwei Chen, et al.
Nature Communications|November 10, 2022
Lipidomic signatures align with inflammatory patterns and outcomes in critical illnessJunru Wu, Anthony Cyr, Danielle S Gruen, et al.
Trauma Surgery & Acute Care Open|January 23, 2025
High-grade liver injury: outcomes with a trauma surgery-liver surgery collaborative approachRafael G Ramos-Jimenez, Andrew-Paul Deeb, Evelyn I Truong, et al.
The Journal of Trauma and Acute Care Surgery|February 17, 2025
Predictive value of platelet function assays in traumatic brain injury patients on antiplatelet therapyNijmeh Alsaadi, Reem Younes, Jack R Killinger, et al.
Research and Practice in Thrombosis and Haemostasis|July 4, 2025
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trialSylvain A Lother, Wen Teng, Olawale Ayilara, et al.
Nature Nanotechnology|July 19, 2022
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motifMichelle A Cruz, Dillon Bohinc, Elizabeth A Andraska, et al.
Annals of Surgery|October 16, 2020
Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma TrialsJohn B Holcomb, Ernest E Moore, Jason L Sperry, et al.
Circulation|June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled TrialScott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.
The Journal of Trauma and Acute Care Surgery|January 23, 2026
Platelet function assays fail to detect differences between transfusion of cold or room temperature platelets in traumatic brain injury patientsJack R Killinger, Nijmeh Alsaadi, James F Luther, et al.
Pageof 26